What does the evidence say about Hmb Muscle Mass Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Hmb Muscle Mass Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - Conclusion Acute post-exercise HMB-FA supplementation in elite judo athletes did not significantly influence muscle damage or oxidative stress markers but transiently increased antioxidant enzyme activities (CAT, GPX, and SOD). [Tayebi SM (2026); evidence level 2] - Purpose High-intensity judo bouts induce oxidative stress and muscle damage, impairing recovery. [Tayebi SM (2026); evidence level 2] - This randomized, double-blind, placebo-controlled pilot trial examined whether acute β -hydroxy- β -methylbutyrate free acid (HMB-FA) supplementation influences muscle damage, oxidative stress, and antioxidant biomarkers in elite judoka. [Tayebi SM (2026); evidence level 2] - 1 2 3 4 5 Older age is associated with declines in skeletal muscle mass, strength and function, termed sarcopenia []. [Smith Kenneth (2026); evidence level 2] - Involving motor unit remodelling and muscle fibre atrophy as a result of lifestyle, genetic and disease interactions, sarcopenia is a major hurdle to improving health-span against the backdrop of increasing lifespan. [Smith Kenneth (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.